GPRC5D and neoplasm: Interestingly, the “GPRC5D high, Efficacy low” sample showed a low immune score, and the “GPRC5D low, Efficacy high” sample showed a high immune score (Supplemental Fig. 4c), indicating that immune cells are contributing to the anti-tumor activity induced by BsAb5003.